Nyamyc Powder
NDC Package 0832-0465-60
Package Information
Nyamyc (nystatin) powders is nystatin is used to treat fungal skin infections. This formulation utilizes a powder delivery system. Marketed by Upsher-smith Laboratories, Llc, this product is identified by NDC 0832-0465 and is authorized under FDA application ANDA065183.
Identification & Billing
- RxCUI: 584414 - Nyamyc 100,000 UNT/GM Topical Powder
- RxCUI: 584414 - nystatin 100 UNT/MG Topical Powder [Nyamyc]
- RxCUI: 584414 - Nyamyc 100 UNT/MG Topical Powder
- RxCUI: 646456 - nystatin 100,000 UNT/GM Topical Powder
- RxCUI: 646456 - nystatin 100 UNT/MG Topical Powder
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0832 - Upsher-smith Laboratories, Llc
- 0832-0465 - Nyamyc
- 0832-0465-60 - 1 BOTTLE, PLASTIC in 1 CARTON / 60 g in 1 BOTTLE, PLASTIC
- 0832-0465 - Nyamyc
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0832-0465). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0832-0465-60 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 60 g in 1 bottle, plastic of Nyamyc, a human prescription drug labeled by Upsher-smith Laboratories, Llc. This powder is formulated for topical use and contains nystatin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Upsher-smith Laboratories, Llc on May 03, 2005. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Nystatin is used to treat fungal skin infections. Nystatin is an antifungal that works by stopping the growth of fungus.
How is this Upsher-smith Laboratories, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00832046560. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.